Draft:Miquel Bernardo Arroyo

Submission declined on 27 February 2024 by Utopes (talk).

This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.

If you would like to continue working on the submission, click on the "Edit" tab at the top of the window.
If you have not resolved the issues listed above, your draft will be declined again and potentially deleted.
If you need extra help, please ask us a question at the AfC Help Desk or get live help from experienced editors.
Please do not remove reviewer comments or this notice until the submission is accepted.

Where to get help

If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews.
If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed.

How to improve a draft

Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia.
Help:Wikitext – how to use the markup
Help:Referencing for beginners – how to include references
Wikipedia:Article development – how to develop your article
Wikipedia:Writing better articles – how to improve your article
Wikipedia:Verifiability – make sure your article includes reliable third-party sources

You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article.

Improving your odds of a speedy review

To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags.

Add tags to your draft

Editor resources

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs

Declined by Utopes 2 months ago. Last edited by Citation bot 2 months ago. Reviewer: Inform author.

Resubmit

Please note that if the issues are not fixed, the draft will be declined again.

Comment: Own publications should not be used as references. Significant coverage from reliable, independent sources is required to establish notability. Utopes _{(talk / cont)} 17:32, 27 February 2024 (UTC)

Miquel Bernardo Arroyo was born in 1954, Barcelona, Spain. He is a psychiatrist and a Full Professor of Psychiatry at the University of Barcelona. Is known for his work in the field of schizophrenia and related disorders.^[1]^[2]

Early life[edit]

Miquel Bernardo Arroyo completed his medical studies at the University of Barcelona, graduating in 1978. He completed his residency training at the Hospital Clínic of Barcelona and obtained his specialization in Psychiatry in 1982. In 1983, he received the End-of-Residency Award from the Hospital Clínic de Barcelona. He earned his PhD in medicine from the University of Barcelona in 1991, graduating Cum Laude.^{[citation needed]}

Research[edit]

Bernardo is a researcher in the field of schizophrenia.^[3] His research primarily focuses on initial psychotic episodes, early stages of the illness, physical health, lifestyle factors, biomarkers, translational and precision psychiatry, inflammation in schizophrenia, neuropsychology, psychological interventions, psychometric testing, neuropsychopharmacology, and biological therapies. ^{[citation needed]}

Bernardo is the lead investigator for PEPs and 2 EPs (Spanish coordinated multicenter projects) involving 16 hospitals in the follow-up of patients with first psychotic episodes over 15 years.^[4] These projects focuses on identifying genetic and environmental factors of risk and their interaction in the appearance of a first-episode psychosis. Also, these projects have generated around 67 publications at the moment with an impact factor of 285 in the journals of schizophrenia and psychosis.^[5]

Career[edit]

Having more than 30 years of professional experience, Miquel Bernardo is presently a professor at the University of Barcelona, Spain, coordinator of Psychiatry. During his tenure at the University Clínic Hospital of Barcelona, he held different positions including Senior Consultant, Founder and Director of the Schizophrenia Clínic Unit.^{[citation needed]}

He was principal investigator of the CIBERSAM Schizophrenia Program at the Hospital Clínic of Barcelona and currently Group lider of the schizophrenia at the Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS).

Awards and honors[edit]

Bernardo has been honored with many awards including Institut d'Estudis Catalans Prize, August Pi-Sunyer Award for his research career, Catalan Society of Psychiatry, Best in Class Award for the Best Schizophrenia Unit of the National Health Service, Professional Excellence Award by the College of Physicians of Barcelona and the Spanish Society of Psychiatry's Award (2019) for his professional career. ^{[citation needed]}

Bernardo has been awarded an International Distinguished Fellowship by the American Psychiatric Association and is an Honorary Partner of several scientific societies including Psychiatric Association of Latin America, Spanish Society of Dual Pathology, and Spanish Society of Biological Psychiatry.^[6] He is currently the president of the Spanish Foundation for Psychiatry and Mental Health (FEPSM).^[7]

Publication[edit]

Bernardo published 16 books some of which have been republished, and written 75 book chapters. More than 430 articles and they have an overall impact factor of 2293.41 (FI JCR 2021) and an H-Index of 51 (SCOPUS).

Miquel Bernardo, Miquel Bioque, Mara Parellada, Jerónimo Saiz Ruiz, Manuel J Cuesta, Adrián Llerena, Julio Sanjuán, Josefina Castro-Fornieles, Celso Arango, Bibiana Cabrera, PEPsGroup. "Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs)". Revista de Psiquiatría y Salud Mental (English Edition).^[8]
Miguel Bernardo, Anna Coma, Cristina Ibáñez, Corinne Zara, Josep Maria Bari, Antoni Serrano-Blanco. "Antipsychotic polypharmacy in a regional health service: a population-based study". BMC psychiatry.^[9]
Miguel Bernardo, Miquel Bioque, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Laura Pina, Iluminada Corripio, Julio Sanjuán, Anna Mané, Josefina Castro-Fornieles, Eduard Vieta, Celso Arango, Gisela Mezquida, Patricia Gassó, Mara Parellada, JerónimoSaiz-Ruiz, Manuel J Cuesta, Sergi Mas, PEPs. Group. "Modelling gene-environment interaction in first episodes of psychosis". Schizophrenia research.^[10]
Jim van Os, T Burns, Roberto Cavallaro, S Leucht, Joseph Peuskens, L Helldin, M Bernardo, C Arango, W Fleischhacker, B Lachaux, JM Kane. "Standardized remission criteria in schizophrenia". Acta Psychiatrica Scandinavica.^[11]
Emilio Fernandez-Egea, Miguel Bernardo, Thomas Donner, Ignacio Conget, Eduard Parellada, Azucena Justicia, EnricEsmatjes, Clemente Garcia-Rizo, Brian Kirkpatrick. "Metabolic profile of antipsychotic-naive individuals with non-affective psychosis'. The British journal of psychiatry.^[12]

References[edit]

^ "clinicbarcelona.org".
^ "Miquel Bernardo". Institut de Neurociències. Retrieved 2023-09-20.
^ "unirioja.es".
^ Parellada, Mara; Janssen, Joost; Mezquida, Gisela; Bernardo Arroyo, Miguel; Arango, Celso; Díaz-Caneja, Covadonga; Martínez, Kenia; Pina-Camacho, Laura; Santonja, Javier (2020). "T25. The Relationship Between Age at First-Episode and Longitudinal Cortical Changes in First-Episode Psychosis: A Two-Year Longitudinal Study in an Adolescent and Adult-Onset Cohort". Schizophrenia Bulletin. pp. S240–S241. doi:10.1093/schbul/sbaa029.585. PMC 7234220. Retrieved 2023-09-20.
^ Bernardo, Miquel; Cabrera, Bibiana; Arango, Celso; Bioque, Miquel; Castro-Fornieles, Josefina; Cuesta, Manuel Jesús; Lafuente, Amalia; Parellada, Mara; Saiz-Ruiz, Jeronimo; Vieta, Eduard (2019-07-01). "One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry". Revista de Psiquiatría y Salud Mental (English Edition). 12 (3): 135–140. doi:10.1016/j.rpsmen.2019.08.001. ISSN 2173-5050. PMID 31103407. S2CID 203469553.
^ Segura, Àlex-González; Prohens, Llucia; Mezquida, Gisela; Amoretti, Silvia; Bioque, Miquel; Ribeiro, María; Gurriarán-Bas, Xaquin; Rementería, Lide; Berge, Daniel; Rodriguez-Jimenez, Roberto; Roldán, Alexandra; Pomarol-Clotet, Edith; Ibáñez, Angela; Usall, Judith; García-Portilla, Maria Paz (2022-07-22). "Epigenetic clocks in relapse after a first episode of schizophrenia". Schizophrenia. 8 (1): 61. doi:10.1038/s41537-022-00268-2. ISSN 2754-6993. PMC 9307769. PMID 35869075.
^ "Fundación Española de Psiquiatría y Salud Mental". fepsm.org. Retrieved 2023-09-20.
^ Bernardo, Miquel; Bioque, Miquel; Parellada, Mara; Ruiz, Jerónimo Saiz; Cuesta, Manuel J.; Llerena, Adrián; Sanjuán, Julio; Castro-Fornieles, Josefina; Arango, Celso; Cabrera, Bibiana (2013-01-01). "Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs)". Revista de Psiquiatría y Salud Mental (English Edition). 6 (1): 4–16. doi:10.1016/j.rpsmen.2012.11.001. ISSN 2173-5050. PMID 23206389.
^ Bernardo, Miguel; Coma, Anna; Ibáñez, Cristina; Zara, Corinne; Bari, Josep Maria; Serrano-Blanco, Antoni (2012-05-15). "Antipsychotic polypharmacy in a regional health service: a population-based study". BMC Psychiatry. 12 (1): 42. doi:10.1186/1471-244X-12-42. ISSN 1471-244X. PMC 3511232. PMID 22587453.
^ Bernardo, Miguel; Bioque, Miquel; Cabrera, Bibiana; Lobo, Antonio; González-Pinto, Ana; Pina, Laura; Corripio, Iluminada; Sanjuán, Julio; Mané, Anna; Castro-Fornieles, Josefina; Vieta, Eduard; Arango, Celso; Mezquida, Gisela; Gassó, Patricia; Parellada, Mara (2017-11-01). "Modelling gene-environment interaction in first episodes of psychosis". Schizophrenia Research. 189: 181–189. doi:10.1016/j.schres.2017.01.058. ISSN 0920-9964. PMID 28179063. S2CID 24528002.
^ Os, J.; Burns, T.; Cavallaro, R.; Leucht, S.; Peuskens, J.; Helldin, L.; Bernardo, M.; Arango, C.; Fleischhacker, W.; Lachaux, B.; Kane, J. M. (February 2006). "Standardized remission criteria in schizophrenia". Acta Psychiatrica Scandinavica. 113 (2): 91–95. doi:10.1111/j.1600-0447.2005.00659.x. ISSN 0001-690X. PMID 16423159. S2CID 25217851.
^ Fernandez-Egea, Emilio; Bernardo, Miguel; Donner, Thomas; Conget, Ignacio; Parellada, Eduard; Justicia, Azucena; Esmatjes, Enric; Garcia-Rizo, Clemente; Kirkpatrick, Brian (May 2009). "Metabolic profile of antipsychotic-naive individuals with non-affective psychosis". British Journal of Psychiatry. 194 (5): 434–438. doi:10.1192/bjp.bp.108.052605. ISSN 0007-1250. PMC 2703813. PMID 19407273.

External links[edit]

Miquel Bernardo Arroyo publications indexed by Google Scholar

[1] "clinicbarcelona.org".

[2] "Miquel Bernardo". Institut de Neurociències. Retrieved 2023-09-20.

[3] "unirioja.es".

[4] Parellada, Mara; Janssen, Joost; Mezquida, Gisela; Bernardo Arroyo, Miguel; Arango, Celso; Díaz-Caneja, Covadonga; Martínez, Kenia; Pina-Camacho, Laura; Santonja, Javier (2020). "T25. The Relationship Between Age at First-Episode and Longitudinal Cortical Changes in First-Episode Psychosis: A Two-Year Longitudinal Study in an Adolescent and Adult-Onset Cohort". Schizophrenia Bulletin. pp. S240–S241. doi:10.1093/schbul/sbaa029.585. PMC 7234220. Retrieved 2023-09-20.

[5] Bernardo, Miquel; Cabrera, Bibiana; Arango, Celso; Bioque, Miquel; Castro-Fornieles, Josefina; Cuesta, Manuel Jesús; Lafuente, Amalia; Parellada, Mara; Saiz-Ruiz, Jeronimo; Vieta, Eduard (2019-07-01). "One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry". Revista de Psiquiatría y Salud Mental (English Edition). 12 (3): 135–140. doi:10.1016/j.rpsmen.2019.08.001. ISSN 2173-5050. PMID 31103407. S2CID 203469553.

[6] Segura, Àlex-González; Prohens, Llucia; Mezquida, Gisela; Amoretti, Silvia; Bioque, Miquel; Ribeiro, María; Gurriarán-Bas, Xaquin; Rementería, Lide; Berge, Daniel; Rodriguez-Jimenez, Roberto; Roldán, Alexandra; Pomarol-Clotet, Edith; Ibáñez, Angela; Usall, Judith; García-Portilla, Maria Paz (2022-07-22). "Epigenetic clocks in relapse after a first episode of schizophrenia". Schizophrenia. 8 (1): 61. doi:10.1038/s41537-022-00268-2. ISSN 2754-6993. PMC 9307769. PMID 35869075.

[7] "Fundación Española de Psiquiatría y Salud Mental". fepsm.org. Retrieved 2023-09-20.

[8] Bernardo, Miquel; Bioque, Miquel; Parellada, Mara; Ruiz, Jerónimo Saiz; Cuesta, Manuel J.; Llerena, Adrián; Sanjuán, Julio; Castro-Fornieles, Josefina; Arango, Celso; Cabrera, Bibiana (2013-01-01). "Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs)". Revista de Psiquiatría y Salud Mental (English Edition). 6 (1): 4–16. doi:10.1016/j.rpsmen.2012.11.001. ISSN 2173-5050. PMID 23206389.

[9] Bernardo, Miguel; Coma, Anna; Ibáñez, Cristina; Zara, Corinne; Bari, Josep Maria; Serrano-Blanco, Antoni (2012-05-15). "Antipsychotic polypharmacy in a regional health service: a population-based study". BMC Psychiatry. 12 (1): 42. doi:10.1186/1471-244X-12-42. ISSN 1471-244X. PMC 3511232. PMID 22587453.

[10] Bernardo, Miguel; Bioque, Miquel; Cabrera, Bibiana; Lobo, Antonio; González-Pinto, Ana; Pina, Laura; Corripio, Iluminada; Sanjuán, Julio; Mané, Anna; Castro-Fornieles, Josefina; Vieta, Eduard; Arango, Celso; Mezquida, Gisela; Gassó, Patricia; Parellada, Mara (2017-11-01). "Modelling gene-environment interaction in first episodes of psychosis". Schizophrenia Research. 189: 181–189. doi:10.1016/j.schres.2017.01.058. ISSN 0920-9964. PMID 28179063. S2CID 24528002.

[11] Os, J.; Burns, T.; Cavallaro, R.; Leucht, S.; Peuskens, J.; Helldin, L.; Bernardo, M.; Arango, C.; Fleischhacker, W.; Lachaux, B.; Kane, J. M. (February 2006). "Standardized remission criteria in schizophrenia". Acta Psychiatrica Scandinavica. 113 (2): 91–95. doi:10.1111/j.1600-0447.2005.00659.x. ISSN 0001-690X. PMID 16423159. S2CID 25217851.

[12] Fernandez-Egea, Emilio; Bernardo, Miguel; Donner, Thomas; Conget, Ignacio; Parellada, Eduard; Justicia, Azucena; Esmatjes, Enric; Garcia-Rizo, Clemente; Kirkpatrick, Brian (May 2009). "Metabolic profile of antipsychotic-naive individuals with non-affective psychosis". British Journal of Psychiatry. 194 (5): 434–438. doi:10.1192/bjp.bp.108.052605. ISSN 0007-1250. PMC 2703813. PMID 19407273.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]